Diagnostic News and Research

RSS

Single microRNA exhibits potential to forecast outcomes of MPM

Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announced today that the results of a joint study with the NYU Langone Medical Center were published online on February 16th, 2010, and are set to be published in the March 1st issue of the American Association for Cancer Research’s journal, Cancer Research.

18 Feb 2010

Asuragen announces agreement to develop and manufacture RNA Control Kits for Affymetrix

Asuragen Inc., a leading molecular biology diagnostic company and service provider, today announced an agreement to develop and manufacture RNA Control Kits for Affymetrix. The RNA Control Kit is intended for use with in vitro transcription (IVT) reagent kits for clinical molecular diagnostic applications that Asuragen has licensed and supplied to Affymetrix.

18 Feb 2010

Single test is not enough for making accurate diagnosis of disc herniation

While lower back pain ranks as a common cause of disability in the United States, determining what causes a person's back pain is often challenging. A new Cochrane review on diagnosing back pain finds that no single diagnostic test is good at discriminating between patients who have a herniated disc and patients who do not, according to lead author Danielle van der Windt.

18 Feb 2010

NIA develops CardiacConnections program to drive better patient outcomes

Cardiovascular-related examinations account for more than one in three noninvasive diagnostic imaging procedures in the United States. In response to this growing trend and concerns about clinical appropriateness and affordability, National Imaging Associates, a subsidiary of Magellan Health Services, Inc., developed CardiacConnections™, a cardiac management program designed for the benefit of patients, providers, payers, and the health care industry.

18 Feb 2010

Taking zinc supplements reduces otitis media in healthy children: No clear evidence

A new Cochrane review did not find clear evidence that taking zinc supplements reduces the occurrence of middle ear infections or otitis media in healthy children.

18 Feb 2010

Researchers establish Canadian norms for diagnosing FASD

Fetal Alcohol Research, the official journal of FACE, has published breakthrough research by Dr. Sterling Clarren, CEO and Chief Scientific Officer of Canada Northwest FASD Research Network and colleagues, establishing Canadian norms which will allow more accurate diagnosis of Fetal Alcohol Spectrum Disorder (FASD).

18 Feb 2010

BG Medicine, Merck collaborate in development of novel biomarker for lipid disorder management

BG Medicine, Inc. today announced that it has entered into a research collaboration with Merck, through a subsidiary, for the development and validation of a novel biomarker with potential application in the management of lipid disorders. BG Medicine will pursue development and validation of an immunoassay and investigate its clinical utility as a biomarker. If successful, BG Medicine plans to complete the development and validation studies and seek regulatory clearance for the test.

18 Feb 2010

Merge Healthcare signs reseller agreement with Orion Health

Merge Healthcare announced today that it has signed a reseller agreement with Orion Health, a leading provider of clinical workflow and integration solutions in healthcare. Orion Health has licensed Merge technology to bring medical images and information into its physician portal solutions.

17 Feb 2010

Study demonstrates usefulness of salivary diagnostics in finding pancreatic cancer

The good news is that there may soon be a new weapon in the battle against the so-called "worst" cancer - cancer of the pancreas. A multidisciplinary group of investigators from the UCLA School of Dentistry, the David Geffen School of Medicine at UCLA, the UCLA School of Public Health and UCLA's Jonsson Comprehensive Cancer Center has demonstrated the usefulness of salivary diagnostics in the effort to find and fight the disease.

17 Feb 2010

MEDecision launches InFrame collaborative HIE service

MEDecision, Inc., a leading provider of collaborative healthcare management solutions, today introduced the next generation of its healthcare management technology with the launch of InFrame™, a collaborative health information exchange (HIE) service that enables care delivery organizations to share clinical data — including diagnostic-quality medical images — among themselves and with patients to more effectively drive business and comply with meaningful use criteria.

17 Feb 2010

Covidien, IAE POLATOM announce agreement to augment supply of Mo 99 to produce Tc 99m

Covidien, a leading global provider of healthcare products, and the Institute of Atomic Energy in Poland today announced an agreement to augment and further diversify Covidien’s supply of Molybdenum 99 (Mo 99) to produce the medical isotope Technetium 99m (Tc 99m).

17 Feb 2010

Medical journal finds divide between doctors and patients on new mammogram recommendations

News outlets explore confusion about cancer screening guidelines and questions raised about the effects of high tech procedures on health care costs and quality.

17 Feb 2010

Iowa State University researchers awarded 30 ARRA grants worth $16.38M

Iowa State University researchers have so far won 30 grants worth a total $16.38 million from federal agencies awarding money from the American Recovery and Reinvestment Act (ARRA).

17 Feb 2010

Study: Earlier detection of lung cancer can reduce number of late stage lung cancer deaths

The first ever actuarial analysis of lung cancer mortality, published today in Population Health Management Journal, provides strong evidence that earlier detection could reduce the number of late stage lung cancer deaths by over 70,000 people each year in the US.

17 Feb 2010

Exagen Diagnostics, EndoChoice announce agreement for promoting diagnostic services to U.S. gastroenterologists

Exagen Diagnostics, Inc., a molecular diagnostics laboratory that discovers, develops and markets proprietary genomic tests, today announced an exclusive sales and marketing agreement with EndoChoice, Inc. to promote its diagnostic services to gastroenterologists throughout the United States.

17 Feb 2010

Sequenom CMM launches SensiGene Fetal Sex Determination test

Sequenom, Inc. today announced the launch of the SensiGene™ Fetal(XY) (Fetal Sex Determination) test by Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM). This is the company's second laboratory developed test powered by its SEQureDx™ technology.

17 Feb 2010

FDA’s radiation exposure-reduction initiative: HealthHelp’s model provides quality and safety

The Federal Food and Drug Administration’s (FDA) recently announced radiation exposure-reduction initiative acknowledges the vital need for industry-wide quality and safety measures like the ones HealthHelp provides its payer clients.

16 Feb 2010

SimMan 3G robotic patient helps pharmacy students practice diagnostic skills

A robot that can be programmed to have a range of medical conditions, from heart disease to constipation, is being used by Pharmacy students at the University of Bath to help practise diagnostic skills and treating patients.

16 Feb 2010

BayCare Health System opens all-digital, state-of-the-art facility in North Tampa

St. Joseph's Hospital-North, part of BayCare Health System, offers emergency care, surgical services, imaging and diagnostic facilities, intensive care and more in a peaceful, healing and family-centered environment. Located just north of Tampa in Lutz, the all-digital, state-of-the-art facility is specially designed to make patients and visitors as comfortable as possible during their hospital experience.

16 Feb 2010

Nascent symptoms of autism in infants emerge during latter part of first year of life

A study of the development of autism in infants, comparing the behavior of the siblings of children diagnosed with autism to that of babies developing normally, has found that the nascent symptoms of the condition - a lack of shared eye contact, smiling and communicative babbling - are not present at 6 months, but emerge gradually and only become apparent during the latter part of the first year of life.

16 Feb 2010

Diagnostic News and Research

Single microRNA exhibits potential to forecast outcomes of MPM

Asuragen announces agreement to develop and manufacture RNA Control Kits for Affymetrix

Single test is not enough for making accurate diagnosis of disc herniation

NIA develops CardiacConnections program to drive better patient outcomes

Taking zinc supplements reduces otitis media in healthy children: No clear evidence

Researchers establish Canadian norms for diagnosing FASD

BG Medicine, Merck collaborate in development of novel biomarker for lipid disorder management

Merge Healthcare signs reseller agreement with Orion Health

Study demonstrates usefulness of salivary diagnostics in finding pancreatic cancer

MEDecision launches InFrame collaborative HIE service

Covidien, IAE POLATOM announce agreement to augment supply of Mo 99 to produce Tc 99m

Medical journal finds divide between doctors and patients on new mammogram recommendations

Iowa State University researchers awarded 30 ARRA grants worth $16.38M

Study: Earlier detection of lung cancer can reduce number of late stage lung cancer deaths

Exagen Diagnostics, EndoChoice announce agreement for promoting diagnostic services to U.S. gastroenterologists

Sequenom CMM launches SensiGene Fetal Sex Determination test

FDA’s radiation exposure-reduction initiative: HealthHelp’s model provides quality and safety

SimMan 3G robotic patient helps pharmacy students practice diagnostic skills

BayCare Health System opens all-digital, state-of-the-art facility in North Tampa

Nascent symptoms of autism in infants emerge during latter part of first year of life

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News